Evidence map›Paper›PMID 30519264›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

1-(5-Bromo-2-hydroxy-4-methoxyphenyl)ethanone [SE1] Inhibits MMP-9 Expression by Regulating NF-κB and MAPKs Signaling Pathways in HT1080 Human Fibrosarcoma Cells.

Fang Gong, YuanYuan Zhang, JiaChao Lin, ChengYong Li, ChunXia Zhou, PengZhi Hong, BoMi Ryu, Zhong-Ji Qian

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Efficacy of Buzhong Yiqi decoction on benign prostatic hyperplasia and its possible mechanism.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Fang GongCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.
YuanYuan ZhangCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.
JiaChao LinCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.
ChengYong LiCollege of Chemistry and Environment, Guangdong Ocean University, Zhanjiang 524088, China.
ChunXia ZhouCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.
PengZhi HongCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.ORCID 0000-0002-5670-5806
BoMi RyuDepartment of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea.
Zhong-Ji QianCollege of Chemistry and Environment, Guangdong Ocean University, Zhanjiang 524088, China.ORCID 0000-0001-9220-2600
Guangdong Ocean University · CNJeju National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hippocampus is a traditional medicine in China, which can be used for treating tumors, aging, fatigue, thrombosis, inflammation, hypertension, prostatic hyperplasia, and other diseases. 1-(5-Bromo-2-hydroxy-4-methoxyphenyl)ethanone [SE1] from seahorse (

Identifiers

PMID30519264
PMCPMC6241244
OpenAlexW2900438791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.